HiFiBiO CEO shares how uses AI to transform drug development
CEO & Founder Conversations
•
2m 48s
Liang Schweizer, PhD, Founder & CEO of HiFiBiO, shares how the company stands out in biotech and uses AI to transform drug development on #NYSEFloorTalk with Judy Shaw.
Up Next in CEO & Founder Conversations
-
JLL Work Dynamics CEO on futureproofi...
Neil Murray, CEO of JLL Work Dynamics, joins Judy Shaw on
#NYSEFloorTalk to discuss how JLL is helping clients futureproof offices as hybrid workstyles evolve. From leveraging advanced technologies to optimize modern workplaces to strategies for attracting and retaining top talent, Neil provide... -
Veralto CEO on the company's first ye...
Jennifer Honeycutt, CEO of Veralto, reflects on the company’s first year, recent Q3 results, and its exciting first acquisition since the spinoff of Danaher on #NYSEFloorTalk with Judy Shaw.
-
Natalya Thakur, CEO, Knox Networks, s...
Natalya Thakur, CEO of Knox Networks, joins Judy Shaw on #NYSEFloorTalk to share how the company is driving innovation in the fintech space. From groundbreaking solutions to key milestones achieved this year, Natalya highlights what sets Knox Networks apart and gives us a glimpse into the excitin...
